Standards for reporting prognostic tumor marker studies

Editorial

Todd A Alonzo. J Clin Oncol. 2005.

. 2005 Dec 20;23(36):9053-4.

doi: 10.1200/JCO.2005.04.3778. Epub 2005 Nov 21.

No abstract available

Comment on

High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor.
Dome JS, Bockhold CA, Li SM, Baker SD, Green DM, Perlman EJ, Hill DA, Breslow NE. Dome JS, et al. J Clin Oncol. 2005 Dec 20;23(36):9138-45. doi: 10.1200/JCO.2005.00.562. Epub 2005 Sep 19. J Clin Oncol. 2005. PMID: 16172460
Reporting recommendations for tumor marker prognostic studies.
McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics. McShane LM, et al. J Clin Oncol. 2005 Dec 20;23(36):9067-72. doi: 10.1200/JCO.2004.01.0454. Epub 2005 Sep 19. J Clin Oncol. 2005. PMID: 16172462 No abstract available.